Computational dissociation of dopaminergic and cholinergic effects on voluntary behavior and inhibitory control

Abstract

BackgroundPatients with schizophrenia make more errors than healthy subjects on the antisaccade task. In this paradigm, participants are required to inhibit a reflexive saccade to a target and to select the correct action (a saccade in the opposite direction). While the precise origin of this deficit is not clear, it has been connected to aberrant dopaminergic and cholinergic neuromodulation. MethodsTo study the impact of dopamine and acetylcholine on inhibitory control and action selection, we administered two selective drugs (levodopa 200mg/galantamine 8mg) to healthy volunteers (N=100) performing the antisaccade task. A computational model (SERIA) was employed to separate the contribution of inhibitory control and action selection to empirical reaction times and error rates. ResultsModeling suggested that levodopa improved action selection (at the cost of increased reaction times) but did not have a significant effect on inhibitory control. By contrast, according to our model, galantamine affected inhibitory control in a dose dependent fashion, reducing inhibition failures at low doses and increasing them at higher levels. These effects were sufficiently specific that the computational analysis allowed for identifying the drug administered to an individual with 70% accuracy. ConclusionsOur results do not support the hypothesis that elevated tonic dopamine strongly impairs inhibitory control. Rather levodopa improved the ability to select correct actions. Instead, inhibitory control was modulated by cholinergic drugs. This approach may provide a starting point for future computational assays that differentiate neuromodulatory abnormalities in heterogeneous diseases like schizophrenia.